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Abstract
Background: Taiwan has integrated the previous vertical tuberculosis (TB) control system into the general health
care system. With the phase out of the specialized TB care system and the declining TB incidence, it is likely that
clinical workers become less familiar with the presentation of TB, resulting in delay in TB diagnosis and treatment.
Methods: We used the detailed information of health care visits in the Taiwan National Health Insurance database to
analyze the temporal pattern of the health system delay (HSD) among 3,117 patients with TB between 2003 and 2010.
Results: The median HSD was 29 days (interquartile range 5–73 days), and the median delay increased from 26 days in
2003 to 33.5 days in 2008, thereafter slightly decreased to 32 days in 2010. Patient factors associated with a longer HSD
included: aged 45–64 and ≧65 years (as compared to aged <30 years); females (as compared to males); an initial visit
as an outpatient (as compared to an inpatient). Provider factors were an initial visit to a provider not specialized in
TB (as compared to a TB-related provider), to a primary care clinic or to a medical center (as compared to a
district hospital), and in Central region, Northern region, KaoPing region, Southern region and Taipei region
(as compared to in Eastern region). Longer distances from the point of initial visit to that of treatment were
associated with longer HSD. Patients who switched among different levels or different types of medical care
services during their illness exhibited the longest HSD.
Conclusions: In countries where the TB care systems are being restructured from a vertical to a horizontal
system, it is critical to monitor HSD and be aware of its increase. The potential increase in the HSD from 2003
to 2008 observed in this study is concerning and the decline of HSD after 2008 might be attributed to the
launch of contact investigation. Our results call for actions to improve the efficiency of TB diagnosis in the
health care system and to increase the awareness of TB among physicians and the general public.
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Background
Tuberculosis (TB) remains a major cause of morbidity
and mortality among all communicable diseases in
Taiwan [1]. Although the incidence and mortality of TB
in Taiwan have been decreasing, the decline rate has slo-
wed down in recent years [2, 3]. TB case finding in
Taiwan mainly depends on the identification of symptom-
atic patients presenting themselves at health care facilities,
supplemented by contact tracing and active screening in
high risk groups. Because of the non-specific clinical man-
ifestations of TB, health care workers might fail to identify
patients with presumptive TB, resulting in substantial
delay in the diagnosis and treatment of TB and an in-
creased risk of transmission [4, 5].
Since the health sector reform in 2002, Taiwan has
integrated the previous vertical TB control system into
the general health care system [6]. With the phase out of
the specialized TB care system and the declining TB
incidence, it is likely that clinical workers become less
familiar with the presentation of TB [7]. As a result, the
interval from the initial medical consultation of a patient
to the treatment of TB (health system delay, HSD) [8, 9]
could have increased in Taiwan over the past years.
Meanwhile, if the general health care system is not
efficient in promptly identifying patients with TB, the
patients might need to make repeated visits within the
health care system for a prolonged period before being
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diagnosed with TB [10]. Using a cohort of new TB pa-
tients, we investigated the temporal pattern of HSD and
its determinants in Taiwan between 2003 and 2010.
Methods
Study population
The study population included all patients with incident
TB between 2003 and 2010 from the cohort of Longitu-
dinal Health Insurance Database 2000 (LHID2000) (http://
nhird.nhri.org.tw/en/index.html). To ensure the representa-
tiveness, the research database of LHID2000 contains all
the original claims data of a total of 1,000,000 individuals
who were randomly sampled from the 23 million benefi-
ciaries enrolled between 1996 and 2000 in the National
Health Insurance (NHI) programme [11]. LHID2000 con-
tains all the registration and claims data including
utilization of inpatient and outpatient services by the
1,000,000 individuals. The NHI covers more than 98 % of
the total population in Taiwan [12]. The four levels of
health care system in Taiwan, from the lower level to the
higher level, are local clinic, district hospital, regional hos-
pital, and medical center (tertiary medical service). People
can choose to go to all four levels of health care facilities
directly, and can be seen by non-specialists or TB special-
ists under the current universal health insurance. The study
was approved by the ethics committee of the National
Taiwan University. Since the data on patient identities were
scrambled cryptographically to protect privacy, informed
consent was exempted by the committee.
Measurement of active tuberculosis
Patients were classified as having incident TB if they
met the following criteria in the LHID2000 during the
follow-up period (2003–2010): (1) at least one medical
visit with TB diagnosis based on the International Classi-
fication of Diseases, 9th Revision, Clinical Modification
(ICD-9-CM) codes 010–018; (2) prescriptions of at least
two anti-TB medications for ≥28 days [13, 14] (Additional
file 1: Figure S1). According to the national guidelines on
TB diagnosis and treatment in Taiwan, the diagnosis of
active TB was based on physical examination, chest radio-
graph, bacteriological evidence from sputum smear and
culture, and a positive response to anti-TB treatment [15].
Laboratory facilities that are able to perform sputum
smear or culture examination for Mycobacterium tubercu-
losis are widely accessible throughout Taiwan [16].
Validation of TB case definition
We used an independent cohort to validate the TB case
definition in the study. Participants of the 2005 National
Health Interview Survey (NHIS) (http://nhis.nhri.org.tw/)
were included in the cohort [17]. The data in the NHIS
cohort (n = 18,526) were cross matched with those in the
NHI database and the TB registry of Taiwan Centers for
Disease Control (CDC). The incident TB case in the NHI
database was identified based on the previously mentioned
ICD-9-CM codes and the prescriptions of two anti-TB
medications for ≥28 days (NHI-based), whereas the con-
firmation of TB in the TB registry was based on bacterio-
logical evidence and clinical information [15]. Assuming
the notification in the TB registry was the gold standard,
we estimated that the NHI-based TB definition in the
2005 NHIS has a sensitivity and specificity of 87.9 and
99.9 %, respectively. When the anti-TB treatment duration
was changed from ≥28 to ≥56 days, the sensitivity and
specificity of TB became 86.9 and 99.9 %, respectively.
Measurement of health system delay
In this study, we defined HSD as the interval between
the first medical consultation of respiratory-related dis-
eases and the initiation of TB treatment. For each pa-
tient with TB, we extracted claims data associated with
the respiratory-related visits from the LHID2000 ac-
cording to the ICD-9-CM codes, prescriptions, and
medical procedures pertaining to respiratory diseases
(Additional file 2: Table S1, Additional file 3: Table S2
and Additional file 4: Table S3). To identify the first
medical consultation of a TB patient, two sequential
respiratory-related visits were considered belonging to
the same respiratory episode if the interval between the two
visits was ≤60 days, and different respiratory episodes if the
interval was >60 days [18] (Additional file 5: Figure S2).
The observation window for measuring HSD was
15 months before the start of TB treatment. We ex-
cluded patients with chronic respiratory diseases from
the analysis. Such patients were likely to have frequent
respiratory-related visits and therefore their HSD could
not be determined. Chronic respiratory diseases were
defined based on prescriptions of respiratory medicines
for ≥28 days at the baseline (365–730 days before the
initiation of TB treatment). Similarly, patients with
asymptomatic TB or extra-pulmonary TB were not
included in this analysis because of the working defin-
ition of HSD.
Statistical analysis
To examine the pattern of HSD from 2003 to 2010, we
plotted the median and interquartile range (IQR) of
HSD by year and visually inspected the trend. We in-
vestigated patient and provider factors as the HSD
determinants [6, 8, 9]. Patient factors were age group,
sex, monthly salary, and patient type (outpatient vs.
inpatient); provider factors were the specialty type of
the first consultation (TB-related, including Chest,
Chest Surgery, TB, Infectious Disease, and Pulmonary
and Critical Care vs. not specialized in TB), the level
of medical care service (primary care clinic, district
hospital, regional hospital, and medical center) where
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the first consultation was received, and the provider
location of the initial visit (Central, Eastern, KaoPing,
Northern, Southern, and Taipei regions). One continu-
ous variable, care-seeking distance (the Euclidean distance
between the point of the first consultation and that of the
initiation of TB treatment), was included. Because pro-
viders’ location information was only available at the
township level, each provider was assigned the respective
township centroid (XY coordinates) to approximate the
exact location [19].
We treated HSD as time to event data and investigated
the HSD determinants by using survival analysis. Cox
proportional hazards regression was used to estimate the
hazard ratios (HRs) of determinants in both univariable
and multivariable models [20]. Observations in which
the HSD was zero days were randomly assigned a tiny
value (0.01–0.05) to approximate the true model, in
which a fraction of patients had a zero survival time. An
HR <1 indicated that the determinant was associated
with a longer HSD and vice versa.
We further examined a patient’s care-seeking pathways
from the first medical consultation to the initiation of
TB treatment. We marked the patient’s visits in chrono-
logical sequence according to the specialty type and
medical care level, respectively. For example, if a patient
sought three primary care clinics during the TB episode,
his or her care-seeking pathways would be marked as
clinic– > clinic– > clinic. We classified care-seeking path-
ways as “persistent” if the patient continuously visited the
same specialty type or medical care level of provider during
the TB episode; “progressive” if the patient switched from a
provider not specialized in TB to a TB-related provider, or
from a primary care provider to a higher level of medical
care during the study interval; “mixed” if the pattern was
neither “persistent” nor “progressive”. We used SAS 9.3
(SAS Institute Inc., Cary, NC, USA) to perform the statis-
tical analysis and ArcGIS 10.2 (ESRI, Redlands, CA, USA)
to measure the care-seeking distance.
Results
A total of 4,494 patients with incident TB were identi-
fied in the LHID2000 cohort between 2003 and 2010.
The trend of the TB incidence rate in our cohort is simi-
lar to that reported by the Taiwan CDC (Fig. 1a). After
excluding 1,377 patients who had a history of chronic
respiratory diseases before the TB episode, 3,117 patients
were included in the final analysis. The HSD in these
patients was right skewed, with a median of 29 days
(IQR 5–73; range 0–449). Among the 3,117 patients, 520
(17 %) had a HSD of zero days (i.e., TB treatment was
initiated in the first medical consultation of respiratory-
related diseases). Overall, the median HSD increased from
26 days in 2003 to 33.5 days in 2008, thereafter slightly de-
creased to 32 days in 2010 (Fig. 1b). A sensitivity analysis
conducted according to different cut-off intervals (30 and
45 days) between two respiratory-related visits revealed a
similar HSD trend (Additional file 6: Figure S3).
The median HSD differed by age group, sex, monthly
salary, patient type, specialty type, and medical care level
(Table 1). Patients who first presented to primary care
clinics had substantially long HSDs (median 52 days, IQR
18–100). In the multivariable survival (time to treatment)
analysis, patient factors associated with a longer HSD
included aged 45–64 years (adjusted HR = 0.81, 95 % con-
fidence interval [CI] 0.72–0.91) and aged ≧65 years
Fig. 1 Incidence rate of tuberculosis (TB) and health system delay
(HSD): 2003–2010, Taiwan. a Annual TB incidence rate observed in the
study cohort (red line) compared with that reported by the Taiwan
Centers for Disease Control (CDC) (blue line), 2003–2010; b median
HSD (solid line) and the corresponding Q1 (25th percentile) and Q3
(75th percentile) of HSD (dashed lines) according to calendar year
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(adjusted HR = 0.68, 95 % CI 0.62–0.76) as compared to
aged <30 years; females (adjusted HR =0.88, 95 % CI
0.82–0.96) as compared to males; an initial visit as an out-
patient (adjusted HR = 0.54, 95 % CI 0.48–0.60) as com-
pared to an inpatient. Provider factors included an initial
visit to a provider not specialized in TB (adjusted HR =
0.47, 95 % CI 0.42–0.52) as compared to a TB-related pro-
vider, to a primary care clinic (adjusted HR = 0.75, 95 % CI
0.67–0.83) or to a medical center (adjusted HR = 0.79,
95 % CI 0.69–0.90) as compared to a district hospital, and
in Central region (adjusted HR = 0.83, 95 % CI 0.69–0.99),
Northern region (adjusted HR = 0.71, 95 % CI 0.59–0.86),
KaoPing region (adjusted HR = 0.79, 95 % CI 0.66–0.94),
Southern region (adjusted HR = 0.75, 95 % CI 0.62–
0.90) and Taipei region (adjusted HR = 0.80, 95 % CI
0.67–0.95) as compared to in Eastern region. The lon-
ger distance traveled from the point of initial visit to
that of treatment was associated with a longer HSD
(adjusted HR = 0.96, 95 % CI 0.95–0.97) (Table 2). Pa-
tients from Eastern region had traveled the longest
distance to be cured (Additional file 7: Figure S4).
Of the 3,117 patients with TB, a total of 16,419 health
care visits were made before the initiation of TB treatment
(5.2 visits per patient prior to treatment). Furthermore,
Table 1 Characteristics of patients with tuberculosis (TB) and distribution of health system delay (HSD) (n = 3117)
Variable n (%) Median HSD (IQR)a P valuec
Age <0.001
< 30 466 (15.0) 20.5 (2.0–61.0)
≥ 30 and <45 554 (17.8) 26.0 (4.0–65.0)
≥ 45 and <65 957 (30.7) 28.0 (5.0–72.0)
≥ 65 1140 (36.5) 36.0 (7.0–85.0)
Sex <0.001
Female 952 (30.5) 35.5 (7.0–76.0)
Male 2165 (69.5) 26.0 (4.0–70.0)
Salary 0.010
< $17880 NTDd per month 1811 (58.1) 27.0 (4.0–70.0)
≥ $17880 NTD per month 1306 (41.9) 32.0 (7.0–75.0)
Patient typeb <0.001
Inpatient 427 (13.7) 0 (0–24.0)
Outpatient 2690 (86.3) 35.0 (8.0–78.0)
Specialty typeb <0.001
Non-TB-related 2443 (78.3) 40.0 (11.0–85.0)
TB-relatede 674 (21.6) 1.0 (0–24.0)
Medical care levelb <0.001
Medical center 482 (15.4) 14.0 (0–47.0)
Regional hospital 706 (22.6) 10.0 (0–45.0)
District hospital 488 (15.7) 16.0 (1.0–52.0)
Clinic 1441 (46.2) 52.0 (18.0–100.0)
Regionb 0.050
Central 532 (17.1) 30.0 (6.0–77.0)
Eastern 150 (4.8) 14.0 (1.0–53.0)
KaoPing 631 (20.2) 29.0 (5.0–75.0)
Northern 379 (12.1) 32.0 (5.0–72.0)
Southern 501 (16.1) 29.0 (5.0–73.0)




d17 880 NTD (New Taiwan Dollar) is the monthly minimum wage in Taiwan
eChest, Chest Surgery, TB, Infectious Disease, and Pulmonary and Critical Care
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28 % of the patients visited the same specialty type (TB-re-
lated vs. not specialized in TB) throughout the care-
seeking process, 47 % shifted from the non-TB-related to
the TB-related specialty, and 25 % exhibited a mixed pat-
tern. Additionally, 26 % opted for the same medical care
level, 39 % progressed to a higher level, and 35 % exhib-
ited a mixed pattern (Table 3). Patients with the mixed
pattern exhibited the longest HSD (median 63 and
76 days, for the mixed specialty type and the mixed
medical care level, respectively).
Discussion
To our knowledge, this study is the first to characterize
HSD temporally by using detailed claims data of a
population-based cohort. The results suggested that the
HSD could have increased during 2003–2008 in Taiwan.
The analysis of HSD determinants further indicated that
old age, being female, and outpatients were important
patient factors for HSD; provider factors included pri-
mary care clinic, medical center, provider not specialized
in TB, care-seeking distance, and location in Central,
Table 2 Cox proportional hazards analysis on health system delay (HSD) for patients with tuberculosis (TB) in Taiwan (n = 3115)e
Variable Number Person-years Univariable Multivariablec
HR (95 % CI) P value HR (95 % CI) P value
Age
< 30 466 53.2 1.00 1.00
≥ 30 and <45 554 75.5 0.87 (0.77–0.98) 0.030 0.89 (0.79–1.00) 0.050
≥ 45 and <65 957 135.9 0.85 (0.76–0.95) 0.005 0.81 (0.72–0.91) <0.001
≥ 65 1138 198.8 0.72 (0.65–0.80) <0.001 0.68 (0.62–0.76) <0.001
Sex
Female 952 152.8 0.91 (0.84–0.98) 0.021 0.88 (0.82–0.96) 0.003
Male 2163 310.8 1.00 1.00
Salary
< $17880 NTDa per month 1810 261.7 1.00 1.00
≥ $17880 NTD per month 1305 201.9 0.94 (0.87–1.00) 0.080 1.00 (0.93–1.08) 0.901
Patient typeb
Inpatient 427 26.9 1.00 1.00
Outpatient 2688 436.6 0.44 (0.39–0.49) <0.001 0.54 (0.48–0.60) <0.001
Specialty typeb
Non-TB-related 2441 429.5 0.36 (0.33–0.40) <0.001 0.47 (0.42–0.52) <0.001
TB-relatedd 674 34.1 1.00 1.00
Medical care levelb
Medical center 481 46.8 1.09 (0.96–1.23) 0.170 0.79 (0.69–0.90) <0.001
Regional hospital 706 64.9 1.15 (1.02–1.29) 0.010 0.89 (0.79–1.01) 0.079
District hospital 488 53.0 1.00 1.00
Clinic 1440 298.8 0.58 (0.52–0.64) <0.001 0.75 (0.67–0.83) <0.001
Regionb
Central 532 80.5 0.79 (0.66–0.95) 0.010 0.83 (0.69–0.99) 0.045
Eastern 150 17.2 1.00 1.00
KaoPing 630 98.7 0.77 (0.65–0.92) 0.005 0.79 (0.66–0.94) 0.010
Northern 379 59.1 0.78 (0.64–0.94) 0.010 0.71 (0.59–0.86) <0.001
Southern 501 77.8 0.79 (0.66–0.95) 0.010 0.75 (0.62–0.90) 0.002
Taipei 923 130.1 0.83 (0.70–0.99) 0.040 0.80 (0.67–0.95) 0.012
Distance (logarithm) - - 0.94 (0.930.94) <0.001 0.96 (0.95–0.97) <0.001
a$17 880 NTD (New Taiwan Dollar) is the monthly minimum wage in Taiwan
bInitial visit
cAdjusted for all other variables in the table
dChest, Chest Surgery, TB, Infectious Disease, and Pulmonary and Critical Care
eTwo patients whose care visits (initial or the initiation of TB treatment) outside the island of Taiwan were excluded
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Northern, Southern, KaoPing and Taipei regions. Pa-
tients with the mixed pattern of care-seeking pathways
exhibited the longest HSD.
HSD can be divided into three interconnected compo-
nents: a) the interval between the first medical consultation
and the time when a TB diagnostic test is ordered; b) the
interval between the order of diagnostic test and a positive
result (i.e., turnaround time of diagnostic test); c) the inter-
val between the positive diagnostic test and the initiation of
TB treatment. Although we were not able to analyze the
relative contribution of the three components to the overall
HSD, we suspected that the contribution of b and c might
be small. High quality TB diagnosis and free TB treatment
are widely available in Taiwan [16]. Therefore, the long
HSD in our study may be possibly due to the long
interval between the first medical consultation and the
time when TB is suspected. However, a definitive ana-
lysis is still warranted.
The potential increase in HSD between 2003 and 2008
(Fig. 1b) may be a warning message for TB control in
Taiwan. Physicians might have fewer experiences in
handling TB cases because of the continuous decline in
the incidence of TB [3, 7]. The increasing proportion of
elderly patients with TB might have also contributed to
the HSD increase over time [21]. Nonetheless, we note
that the median HSD started to decline after 2008, and
the third quartile of HSD declined since 2007, suggesting
that the number of patients with extreme HSD was
falling (Fig. 1b). One possible reason for the decline was
the effect of contact investigation. Taiwan CDC has
strengthened the effort of contact investigation since
2007, and the number of close contacts under investiga-
tion increased from 2.6 per index case in 2006 to 6.6 per
index case in 2010 [22]. Our analysis suggested that rou-
tinely collected information can be used to continuously
monitor the trend of HSD and to inform policy making.
In the meanwhile, alertness on the presentation of TB
should be emphasized in the continual medical educa-
tion of all physicians.
We found that 17 % of patients have 0 days of HSD,
suggesting that patients were treated on the same day
based on symptoms and results of chest X-ray. In Taiwan,
chest X-ray is widely available as an initial test for TB
diagnosis [15]. In a previous study conducted in Taiwan,
46 % of 1,126 newly diagnosed TB patients were put on
anti-TB treatment immediately based solely on the result
of chest X-ray [23]. We caution that same-day treatment
based on TB symptoms and X-ray might result in substan-
tial over-treatment, because TB symptoms and chest X-
ray tend to have low specificity [24]. Further studies are
needed to identify and quantify the situation of over-
treatment in Taiwan.
The HSD estimate derived in this study is longer than
the result of Chiang et al. (median HSD 23 days) [6] and
shorter than that of Lai (median HSD 53 days) [18]. The
study by Chiang et al. in 2003 was based on interview of
patients with TB in southern Taiwan, and therefore might
be subject to recall bias. However, the study by Lai was a
population-based study in 2005 analyzing claims data of
Taiwanese patients and was unlikely to miss relevant
patient visits. The difference between the HSD values esti-
mated in the current study and that obtained by Lai might
be attributed to our exclusion of patients with TB who
had chronic respiratory diseases at the baseline. The
exclusion was necessary because it was not possible to es-
timate the delay duration in these patients with chronic
respiratory diseases by using a claims database. Compared
with other countries with an intermediate TB disease bur-
den, the HSD in Taiwan remains long. For example, the
median HSD was 15 days in Croatia [25], whereas that
Table 3 Patterns of care-seeking pathways and health system delay (HSD) for patients with tuberculosis (TB) in Taiwan according to
specialty type and medical care level of provider (n = 2597)
Specialty type: TB-relateda(T) versus non-TB-related
(NT)
Medical care level: primary care clinic (C); district hospital (D); regional hospital (R); medical
center (M)
Pattern n (%) Median HSDe (IQR) Pattern n (%) Median HSDe (IQR)
1.Persistentb 1.Persistentb
NT to NT 511 (19.7) 39.0 (13.5–78.0) C to C 82 (3.1) 23.5 (7.5–61.0)
T to T 215 (8.2) 14.0 (7.0–37.0) D to D 119 (4.5) 18.0 (7.0–45.0)
R to R 269 (10.4) 19.0 (7.0–44.0)
M to M 220 (8.5) 19.5 (7.0–42.0)
2.Progressivec 1223 (47.2) 39.0 (13.0–77.0) 2.Progressivec 1001 (38.7) 36.0 (13.0–69.0)
3.Mixedd 648 (24.9) 63.0 (31.0–128.3) 3.Mixedd 906 (34.8) 76.0 (38.0–137.8)
aChest, Chest Surgery, TB, Infectious Disease, and Pulmonary and Critical Care
bPatients continuously visited the same specialty type or level of provider during the TB episode
cPatients switched from non-TB-related provider to TB-related provider or from primary care provider to higher level of medical care during the
care-seeking process
dNeither “persistent” nor “progressive”
eP value <0.001 (Kruskal-Wallis test)
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was 29 days in Taiwan. Similar to Taiwan, Croatia provides
universal health insurance coverage to the whole popula-
tion. But unlike Taiwan, the primary care physicians in
Croatia serve as the gatekeepers to access specialized
ambulatory care [26]. Therefore the differences in HSD
in the two countries might be partly due to different re-
ferral systems.
We identified potential patient and provider factors of
HSD. First, the delay increases as patients become older
(Table 2). Elderly outpatients might present with non-
specific or mild symptoms, making it difficult for general
practitioners to diagnose TB [27, 28]. Female outpatients
might seek medical attention at an earlier stage of dis-
ease (i.e., having a shorter patient delay compared to
male patients) and the diagnosis of early-stage TB could
be more challenging [25, 29]. Our results are consistent
with previous studies that an initial visit to a private
practitioner [28, 30] or to a specialty not specialized in
TB [31, 32] is a risk factor for HSD. Lastly, we found
that the HSD was longer in medical centers than in
district hospitals. One possible explanation is that the
proportion of patients with comorbidity which made
diagnosis of TB difficult was higher in medical centers
than in district hospitals under the current universal
health insurance in Taiwan [33].
We also observed the regional differences of HSD
[31, 34] in Taiwan. Patients from Eastern region had a
surprisingly short delay. We further analyzed the health
system-level characteristics that might affect the HSD
differences among regions. We found that the density
of medical providers, in particular the TB-related pro-
viders, was associated with HSD differences among re-
gions (Additional file 8: Table S4). The regions with the
highest density of TB-related providers (Eastern and
Central) were the regions with the shortest HSD in the
multivariable analysis (Table 2). Additional studies are war-
ranted to understand the exact reasons for the difference.
In the analysis of the care-seeking pathways, a substantial
proportion (25–35 %) of patients with TB exhibited a mixed
(neither “persistent” nor “progressive”) pattern (Table 3).
This suggests that patients were switching among different
levels or different types of medical care services during their
illness. The “doctor shopping” behavior [35] has been docu-
mented among patients with upper respiratory tract infec-
tion, partly due to the ease of accessibility and affordability
of medical care in Taiwan. The HSD among patients
exhibiting the mixed type of care seeking pattern was al-
most twice as long as that of patients in the other groups.
A better understanding and characterization of patients
exhibiting the mixed care-seeking behavior might help to
decrease the HSD in Taiwan. The results of spatial analysis
indicated that a longer distance travel from the point of
initial consultation to that of treatment was associated with
a longer HSD. Patients seeking care before TB diagnosis
might spread the disease when traveling [36]. To reduce
the risks of transmission during care seeking, the referral
mechanism must be strengthened [6].
The current study has some limitations. First, we did
not measure patient delay (the delay from the onset of
illness to the time of initial consultation). Therefore, the
interpretation of HSD determinants should be cautious.
As mentioned, female Taiwanese might have a shorter
patient delay because they are more health conscious
than males, and may present themselves to the health
care setting at the early stage of disease [35]. Because it
is more difficult to diagnose early-stage TB, the female
patients may appear to have a longer HSD. Further stud-
ies that simultaneously measure patient delay and HSD
would be most informative. Second, we used a cut-off
interval of 60 days for distinguishing two respiratory
episodes. Although the sensitivity analysis conducted
using different cut-off intervals (30 and 45 days) revealed
similar HSD trends, additional studies are required to
validate the assumption. Third, because the LHID2000
contains only the medical claims data, information on
whether TB was microbiologically confirmed or not was
not available from the database. Fourth, we excluded pa-
tients with asymptomatic TB or extra-pulmonary TB
based on the current HSD definition. Furthermore, pa-
tients with chronic respiratory diseases were excluded
from the analysis. Thus, the derived results might not be
generalizable to patients with chronic respiratory dis-
eases who may have a longer or shorter HSD than that
of the study’s population. However, this does not affect
the internal validity of the analysis conducted on those
without chronic respiratory diseases. Additionally, the
operational definition of chronic respiratory diseases
must be validated further in the future. Finally, we didn’t
estimate the HSD in recent years (2011 ~ 2014) because
of lack of access to more recent claims data.
Conclusions
The potential increase in the HSD from 2003 to 2008
observed in this study is concerning and it suggested
that the health care system might become less vigilant
about TB during the period of health sector reform. On
the other hand, our historical analysis also revealed that
HSD might be shortened through intensified efforts such
as contact tracing. Our findings suggest that in countries
where the TB care systems are being restructured from a
vertical to a horizontal system, it is critical to monitor
HSD and be aware of its increase. Actions need to be
taken to improve the efficiency of TB diagnosis in the
health care system and to increase the awareness of TB
among physicians and the general public. In the mean-
while, active case finding including contact investigation
and screening of high risk population might help reduce
the delay in TB diagnosis and treatment [37, 38]. Further
Chen et al. BMC Infectious Diseases  (2015) 15:491 Page 7 of 9
studies should be undertaken to continuously monitor
the HSD and to examine the causes of the mixed care-
seeking pattern.
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